Computer-aided detection (CAD) software developer VuCOMP has completed the development of structured reporting for CAD marks on digital breast tomosynthesis (DBT) images.
The company has added tomosynthesis slice information into its structured reporting tools so that workstations can display CAD marks directly on tomosynthesis slices. Tomosynthesis findings can also be shown as enhanced marks on 2D images, VuCOMP said.
This feature will be available as part of VuCOMP's M-Vu CAD software for breast tomosynthesis, which is currently under review by the U.S. Food and Drug Administration (FDA).
